Learn, Analyse & Invest
only with
only with
+91
Download Orca
Blue Cloud Softech Solutions Ltd.
Blue Cloud Softech
Blue Cloud Softech Solutions Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Software & IT Services
Small-cap - With a market cap of ₹18.12 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results & Quarterly Results |
| 19 07 2021 | Issue Of Warrants |
| 12 08 2021 | Issue Of Warrants & Preferential Issue of shares & Quarterly Results Inter alia, • To consider the proposals for fund raising through equity / equity linked instruments / debt instruments and / or any other instrument or security, convertible into Capital, through permissible modes including but not limited to a preferential issue, qualified institution placement, rights issue, further public offer or any other such permissible modes as may be recommended and approved by the Board, in one or more tranches / series, subject to such consents and regulatory / statutory approvals as may be required, in that regard. |
| 13 11 2021 | Quarterly Results |
| 10 12 2021 | Preferential Issue of shares |
| 15 12 2021 | Issue Of Warrants & Inter-alia to allot upto 35,69,200 warrants convertible into Equity Shares on preferential basis. |
| 29 12 2021 | Issue Of Warrants & Inter-alia to consider and approve to convert 1,92,69,200 convertible warrants into Equity Shares. |
| 28 01 2022 | Quarterly Results |
| 16 05 2022 | Audited Results & Quarterly Results |
| 12 08 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 20 01 2023 | Inter alia, to consider the following: 1. Appointment of Ms. Sriveena Vadlamudi (DIN: 07721150) as Whole Time Director of the Company. 2. Appointment of Mr. Manoj Sandilya Telakapalli ( DIN: 09630299) as Whole Time Director of the Company. 3. Any other business with the permission of the Chair. |
| 10 02 2023 | Quarterly Results |
| 16 02 2023 | Preferential Issue of shares |
| 25 05 2023 | Audited Results |
| 14 06 2023 | Inter alia, to consider and approve :- 1. To fix the date and time of 32nd Annual General Meeting for the year ended 31st March, 2023; 2. To consider and approve the Board?s Report as required under Companies Act, 2013; and rules made thereunder and SEBI (LODR) Regulations, 2015. 3. Any other Business with the permission of the Chair. |
| 08 08 2023 | Inter alia, to consider allotment of 16,00,40,000 Equity Shares on preferential basis, wherein The Company is purchasing 4,00,10,000 shares of IT Corpz INC in lieu of issuance of 16,00,40,000 Equity Shares by way of share swap to Mrs. Janaki Yarlagadda (Acquirer 2) (6,00,15,000 Equity Shares), Yas Takaful P.J.S.C. (5,00,12,500 Equity Shares) and Bluesky Capital Fund SPC (5,00,12,500 Equity Shares). The preferential issue made to Mrs. Janaki Yarlagadda will be in the capacity of Promoter (proposed) and to Yas Takaful P.J.S.C and BlueSky Capital Fund SPC will be in the capacity of public shareholders of the Company. |
| 10 08 2023 | Quarterly Results |
| 31 08 2023 | Inter alia, for considering the following agenda: 1. Proposal for acquisition of Indian entities and /or overseas entities. 2. Any other business with the permission of the Chair. |
| 16 09 2023 | Inter alia, to consider: 1. Proposal of Appointment of Executive/Non Executive/ Non Executive Independent Directors. 2. Any other business with the permission of the Chair. |
| 01 11 2023 | Inter alia, to Consider Appointment of Independent Director(s) |
| 14 11 2023 | Quarterly Results |
| 18 12 2023 | Inter alia, tO CONSIDER REQUEST RECEIVED FOR RE-CLASSIFICATION OF PROMOTERS - BM TO BE HELD ON 18.12.2023 |
| 09 02 2024 | Quarterly Results |
| 16 10 2024 | Stock Split |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 07 05 2025 | Preferential Issue of shares & Inter alia, to consider and approve:- 1. To discuss regarding potential acquisition in India or Outside India. 2. Raising of funds by way of issuance of equity shares/convertible warrants including but not limited to through preferential issue and/ or Qualified Institutions Placement (QIP)/ or any other methods on private placement basis, through one or more permissible modes or issue of securities in any combination thereof etc. subject to regulatory approvals, as may be required. The Board, if required, would also consider convening an extra-ordinary general meeting / postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal. 3. Any other business with the permission of the Chair. |
| 23 05 2025 | Inter alia, to consider and approve:- 1. To finalize acquisition Outside India either through CASH or SWAP of Equity Shares or combination thereof. 2. Raising of funds by way of issuance of Foreign Currency Convertible Bonds (FCCBs) subject to regulatory and other approvals, as may be required. 3. Notice convening general meeting / postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal would be shared separately. 4. Any other business with the permission of the Chair. |
| 27 05 2025 | Audited Results |
| 05 06 2025 | Inter-alia to consider the following: 1. Raising of funds by way of issuance of Securities on Preferential Basis subject to regulatory and other approvals, as may be required. 2. Notice convening general meeting / postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal would be shared separately. 3. Any other business with the permission of the Chair. |
| 13 06 2025 | Inter-alia to consider the following: 1. To consider the revised relevant date 10.06.2025 for acquisition of M/s AIS anywhere, a New Jersey based entity as detailed in the outcome of Board Meeting dated 23.05.2025 through SWAP of Equity Shares and arrive at SWAP of shares accordingly. 2. Notice Convening General Meeting to seek approval of the shareholders in respect of the aforesaid proposal would be shared separately. 3. Any other business with the permission of the Chair. |
| 14 08 2025 | Quarterly Results |
| 12 11 2025 | Quarterly Results |
| 10 12 2025 | Inter alia, to consider and approve the Allotment of Equity Shares pursuant to above SWAP |
| 13 02 2026 | Quarterly Results |
| 20 02 2026 | Preferential Issue of shares & Inter alia, to consider and approve the proposal for acquisition of 100% equity stake in a company by way of share swap, subject to receipt of requisite statutory, regulatory and other approvals, including approvals from shareholders, stock exchanges and other authorities, as may be applicable, and upon completion of definitive agreements and fulfilment of customary conditions precedent. |
| 04 04 2026 | Inter alia, to consider and approve :- 1. Considering the proposal for increasing the Authorised Share Capital of the Company 2. Considering the proposal and to authorise /approve the Preferential Issue of Equity Shares as per the applicable regulations of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, subject to such regulatory/statutory approvals as may be required including approval of shareholders of the Company. 3. Fixing the date of Extra-Ordinary General Meeting for seeking shareholders? approval for the above. 4. To consider any other matter with the permission of the chairman. |
| 06 04 2026 | Preferential Issue of shares Inter alia, to consider and approve:- 1. Considering the proposal for increasing the Authorised Share Capital of the Company 2. Considering the proposal and to authorise /approve the Preferential Issue of Equity Shares as per the applicable regulations of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, subject to such regulatory/statutory approvals as may be required including approval of shareholders of the Company. 3. Fixing the date of Extra-Ordinary General Meeting for seeking shareholders? approval for the above. 4. To consider any other matter with the permission |
| 30 04 2026 | Inter alia, to consider and approve:- 1. To consider and approve the making of an application to the National Stock Exchange of India Limited ( NSE ) for listing of the entire issued, subscribed and paid-up equity share capital of the Company on the NSE Main Board under the Direct Listing Route available to companies already listed on a recognized stock exchange, and to authorise the designated signatories in connection therewith and to do all necessary acts, deeds and things for the said listing., and 2. Any other matter with the permission of the Chair. |
| 30 05 2026 | Audited Results & Quarterly Results |
| 14 08 2026 | Quarterly Results |
| 24 08 2026 | Inter alia, to consider and transact the following businesses: 1. To consider and evaluate the proposal for acquisition of equity share capital of an entity engaged in the healthcare sector in the United States of America, having presence across the following segments: (a) AI technology-enabled healthcare solutions; (b) Home care services; (c) Clinical care services; (d) Travel care services; (e) Post-acute care services; (f) Correctional healthcare support; (g) U.S. school education support services; and (h) Mental healthcare services; subject to satisfactory completion of due diligence, valuation, negotiation and such other terms and conditions as may be considered appropriate by the Board. 2. To consider and approve, in principle, the proposed transaction structure, consideration and other commercial terms in connection with the proposed acquisition, subject to applicable regulatory approvals and execution of definitive agreements. 3. To consider the proposal for raising of funds by way of issue of equity shares and/or other eligible securities of the Company on a preferential basis, including by way of swap of shares as consideration for the proposed acquisition, in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, subject to the approval of the members and such other regulatory approvals as may be required. 4. To consider and approve the appointment of legal, financial, tax, technical and other professional advisors / consultants, including a SEBI registered merchant banker and a registered valuer, in connection with the proposed acquisition and the proposed issue of securities, as may be required. 5. To authorize the Whole Time Director and/or the Company Secretary to conduct due diligence, negotiate and finalize the terms of the proposed transaction and, subject to further approval of the Board, execute the definitive documents and instruments as may be required in connection therewith. 6. To consider and approve such other matters incidental and consequential to the foregoing. 7. To transact any other business with the permission of the Chair. |
| 01 09 2026 | A.G.M. |